Hummell D S, Berninger R W, Tomasz A, Winkelstein J A
J Immunol. 1981 Oct;127(4):1287-9.
The present study was performed in order to determine the identity of the pneumococcal cell wall polymer(s) to which C3b becomes fixed after activation of the alternative pathway. Purified pneumococcal autolysin was used to solubilize pneumococcal cell walls to which C3b had been fixed via activation of the alternative pathway. The resulting soluble cell wall polymers were then examined for the presence of C3b. Chromatographic separation of cell wall digests containing either radiolabeled teichoic acid or radiolabeled C3b demonstrated that although the elution profiles of the 2 radiolabels were similar, they were not identical. In addition, when teichoic acid-containing polymers were removed from solution by immunoabsorption with TEPC-15 myeloma, only 43 to 65% of the C3b was removed. These results demonstrate that C3b activated via the alternative pathway fixes both to teichoic acid-containing pneumococcal cell wall polymers and to other cell wall constituents and/or serum proteins bound to the cell wall.
进行本研究是为了确定在替代途径激活后与C3b结合的肺炎球菌细胞壁聚合物的身份。使用纯化的肺炎球菌自溶素来溶解通过替代途径激活后已结合C3b的肺炎球菌细胞壁。然后检查所得的可溶性细胞壁聚合物中是否存在C3b。对含有放射性标记磷壁酸或放射性标记C3b的细胞壁消化物进行色谱分离表明,尽管两种放射性标记的洗脱曲线相似,但并不相同。此外,当用TEPC-15骨髓瘤通过免疫吸附从溶液中去除含磷壁酸的聚合物时,仅去除了43%至65%的C3b。这些结果表明,通过替代途径激活的C3b既结合到含磷壁酸的肺炎球菌细胞壁聚合物上,也结合到其他细胞壁成分和/或与细胞壁结合的血清蛋白上。